Registry for adults with congenital heart disease in Switzerland
Official title: Nationales Register Zur Erfassung Von Erwachsenen Mit Angeborenen Herzfehlern
Run by University Hospital, Basel, Switzerland · NCT02258724 · Data updated 2026-11-12
This study is collecting information from adults with congenital heart disease in Switzerland to better understand their health and improve their treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 6 sites (Basel and 5 other locations) |
| Status | Recruiting |
| Started | September 2013 |
| Main results expected | December 2033 |
| Study ends | December 2033 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT02258724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are adults over 18 years of age with congenital heart disease who have received treatment at specialized centers in Switzerland.
✕Probably not a fit
Patients who do not have congenital heart disease or those who are under 18 years of age will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect and analyze data on adults with congenital heart disease (GUCH patients) who have been treated in specialized centers across Switzerland. It will gather both quantitative and qualitative information, including patient demographics, types of previous treatments, and long-term cardiac complications. By pooling data from various centers, the registry seeks to enhance understanding of the GUCH population and improve treatment strategies. Patients will be asked to participate during their visits and will provide informed consent for their data to be recorded in a secure database.
Why it matters
Potential benefit: If successful, this registry could lead to improved healthcare strategies and treatment outcomes for adults with congenital heart disease.
How similar studies have gone: Other registries focusing on congenital heart disease have shown success in improving patient outcomes and understanding long-term complications, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adult (above 18 years of age) with congenital heart disease, treated in one of the Swiss centre with specialized organisation for GUCH patients. Signed informed consent. Patients with trisomy 21: the parents or legal guardian will have to give the consent. Exclusion Criteria: None
Where it's running
-
Basel University Hospital
Basel, Switzerland Recruiting -
Bern University Hospital Inselspital
Bern, Switzerland Recruiting -
Hôpitaux Universitaires de Genève HUG
Geneva, Switzerland Recruiting -
Centre Hospitalier Universitaire Vaudois CHUV
Lausanne, Switzerland Recruiting -
Kantonsspital St.Gallen
Sankt Gallen, Switzerland Recruiting -
University Hospital Zurich
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Daniel Tobler, MD — University Hospital, Basel, Switzerland
- Study coordinator: Daniel Tobler, MD
- Email: daniel.tobler@usb.ch
- Phone: +41 61 265 52 14
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.